Morphosys Ag (MOR.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 238,278 | 278,267 | 179,612 | 327,698 | 71,755 |
Cost of Goods | 58,355 | 48,620 | 32,195 | 9,174 | 12,085 |
Gross Profit | 179,924 | 229,647 | 147,417 | 318,524 | 59,670 |
Operating Expenses | 430,780 | 450,358 | 425,041 | 300,573 | 167,768 |
Operating Income | -250,856 | -220,711 | -277,624 | 17,952 | -108,098 |
Interest Expense | 109,858 | 116,520 | 65,824 | 96,214 | 2,272 |
Other Income | 169,792 | 354,752 | -247,603 | 100,755 | 3,850 |
Pre-tax Income | -190,922 | 17,521 | -591,050 | 22,492 | -106,520 |
Income Tax | -1,189 | 168,579 | -76,591 | -75,399 | -3,506 |
Net Income Continuous | -189,734 | -151,058 | -514,460 | 97,891 | -103,014 |
Net Income | $-189,734 | $-151,058 | $-514,460 | $97,891 | $-103,014 |
EPS Basic Total Ops | -5.53 | -4.42 | -15.40 | 3.01 | -3.26 |
EPS Basic Continuous Ops | -5.53 | -4.42 | -15.40 | 3.01 | -3.26 |
EPS Diluted Total Ops | -5.53 | -4.42 | -15.40 | 2.97 | -3.26 |
EPS Diluted Continuous Ops | -5.53 | -4.42 | -15.40 | 2.97 | -3.26 |
EBITDA(a) | $-70,528 | $144,576 | $-515,135 | $127,036 | $-98,003 |